Literature DB >> 10748226

Choline release and inhibition of phosphatidylcholine synthesis precede excitotoxic neuronal death but not neurotoxicity induced by serum deprivation.

T Gasull1, N DeGregorio-Rocasolano, A Zapata, R Trullas.   

Abstract

N-Methyl-d-aspartate (NMDA) receptor overactivation has been proposed to induce excitotoxic neuronal death by enhancing membrane phospholipid degradation. In previous studies, we have shown that NMDA releases choline and reduces membrane phosphatidylcholine in vivo. We now observed that glutamate and NMDA induce choline release in primary neuronal cortical cell cultures. This effect is Ca(2+)-dependent and is blocked by MK-801 ((+)-5-methyl-10, 11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine hydrogen maleate). In cortical neurons, the NMDA receptor-mediated choline release precedes excitotoxic cell death but not neuronal death induced by either osmotic lysis or serum deprivation. Glutamate, at concentrations that release arachidonic acid, does not release choline in cerebellar granule cells, unless these cells are rendered susceptible to excitotoxic death by energy deprivation. The NMDA-evoked release of choline is not mediated by phospholipases A(2) or C. Moreover, NMDA does not activate phospholipase D in cortical cells. However, NMDA inhibits incorporation of [methyl-(3)H]choline into both membrane phosphatidylcholine and sphingomyelin. These results show that the increase in extracellular choline induced by NMDA receptor activation is directly related with excitotoxic cell death and indicate that choline release is an early event of the excitotoxic process produced by inhibition of phosphatidylcholine synthesis and not by activation of membrane phospholipid degradation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10748226     DOI: 10.1074/jbc.M910468199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Boosting Endogenous Resistance of Brain to Ischemia.

Authors:  Fen Sun; Stephen R Johnson; Kunlin Jin; Victor V Uteshev
Journal:  Mol Neurobiol       Date:  2016-02-24       Impact factor: 5.590

2.  Choline induces opposite changes in pyramidal neuron excitability and synaptic transmission through a nicotinic receptor-independent process in hippocampal slices.

Authors:  E Albiñana; J G Luengo; A M Baraibar; M D Muñoz; L Gandía; J M Solís; J M Hernández-Guijo
Journal:  Pflugers Arch       Date:  2017-02-08       Impact factor: 3.657

3.  MST1 mediates the N-methyl-D-aspartate-induced excitotoxicity in mouse cortical neurons.

Authors:  Jane Melissa Lim; Rumi Lee; Yeonsil Kim; In Young Lee; Eunju Kim; Eui-Ju Choi
Journal:  Cell Mol Life Sci       Date:  2021-12-30       Impact factor: 9.261

Review 4.  The therapeutic promise of positive allosteric modulation of nicotinic receptors.

Authors:  Victor V Uteshev
Journal:  Eur J Pharmacol       Date:  2014-02-12       Impact factor: 4.432

5.  A type-II positive allosteric modulator of α7 nAChRs reduces brain injury and improves neurological function after focal cerebral ischemia in rats.

Authors:  Fen Sun; Kunlin Jin; Victor V Uteshev
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

6.  Full length Bid is sufficient to induce apoptosis of cultured rat hippocampal neurons.

Authors:  Hans-Georg König; Markus Rehm; Daniel Gudorf; Stan Krajewski; Atan Gross; Manus W Ward; Jochen H M Prehn
Journal:  BMC Cell Biol       Date:  2007-02-27       Impact factor: 4.241

7.  Pharmacological manipulation of cyclic GMP levels in brain restores learning ability in animal models of hepatic encephalopathy: therapeutic implications.

Authors:  Regina Rodrigo; Pilar Monfort; Omar Cauli; Slaven Erceg; Vicente Felipo
Journal:  Neuropsychiatr Dis Treat       Date:  2006-03       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.